Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RLMD

Relmada Therapeutics Inc

6.69

Jun 26 • 04:00PM ET +0.24 (3.72%)

Healthcare Biotechnology USA Small NASD

Peers: AXSM KYMR RYTM INCY NUVL BMRN NBIX VKTX KRYS MDGL

| Held by: VTI VXF XPH PSIL VHT ITOT SBIO AVSC BBC RSSL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	13.80%	Shs Outstand	104.89M	Perf Week	-0.59%
Market Cap	701.72M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.00%	Shs Float	90.42M	Perf Month	-7.85%
Enterprise Value	467.76M	PEG	-	EPS next Q	-0.20	Inst Own	71.73%	Short Float	6.70%	Perf Quarter	2.45%
Income	-58.88M	P/S	-	EPS this Y	42.99%	Inst Trans	32.35%	Short Ratio	4.66	Perf Half Y	49.00%
Sales	0.00M	P/B	3.21	EPS next Y	-16.73%	ROA	-44.77%	Short Interest	6.06M	Perf YTD	38.51%
Book/sh	2.09	P/C	3.00	EPS next 5Y	13.22%	ROE	-48.83%	52W High	8.00 -16.37%	Perf Year	893.91%
Cash/sh	2.23	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-26.92%	52W Low	0.52 1186.51%	Perf 3Y	170.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.93% 6.49%	Perf 5Y	-80.52%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	55.59%	Oper. Margin	-	ATR (14)	0.43	Perf 10Y	-33.63%
Dividend Ex-Date	-	Quick Ratio	18.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.29	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.26	EPS Q/Q	61.90%	SMA20	2.79%	Beta	0.44	Target Price	12.67
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-3.86%	Rel Volume	11.97	Prev Close	6.45
Employees	17	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	41.23%	Avg Volume	1.30M	Price	6.69
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.84% -	Trades		Volume	15,580,678	Change	3.72%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)